-+ 0.00%
-+ 0.00%
-+ 0.00%

ANI PHARMACEUTICALS ANNOUNCES POSITIVE SIX-MONTH TOPLINE DATA FROM THE PHASE 4 OPEN-LABEL, SINGLE-ARM SYNCHRONICITY TRIAL EVALUATING FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT IN PATIENTS WITH CHRONIC NON-INFECTIOUS UVEITIS

Reuters·07/13/2026 10:50:00

Please log in to view news